01.02 Novel Nano-Liposomes for Multi-Modal Image-Guided Lung Cancer Surgery

P. Patel1, T. Kato1, H. Ujiie1, D. Lee1, J. Ahn1, H. Hu1, J. Zheng2,3, K. Yasufuku1,2,3 1University of Toronto,Division Of Thoracic Surgery,Toronto, Ontario, Canada 2University Health Network,TECHNA Institute,Toronto, Ontario, Canada 3University of Toronto,Institute Of Biomaterials & Biomedical Engineering,Toronto, Ontario, Canada

Introduction:
To investigate the feasibility of CF800, a novel PEGylated nano-liposomal imaging agent containing indocyanine green (ICG) and iohexol, for real-time near infrared (NIR) fluorescence and computed tomography (CT) image-guided surgery in an orthotopic lung cancer model in nude mice.

Methods:
CF800 was intravenously administered into 13 mice bearing the H460 orthotopic human non-small cell lung cancer. At 48 h post-injection (peak liposome accumulation time), ex vivo NIR and CT imaging was performed. A clinical NIR imaging system (SPY®, Novadaq) was used to measure the fluorescence intensity of tumor and adjacent lung tissue. Tumor-to-background-ratios (TBR) were calculated in inflated and deflated states. The mean Hounsfield unit (HU) of lung tumor was quantified using the CT data set and a semi-automated threshold-based method. Histological evaluation was performed using Hematoxylin & Eosin, and immunofluorescence macrophage marker F4/80 and endothelial cell marker CD31, and compared to the liposomal fluorescence signal obtained from adjacent tissue sections.

Results:
The fluorescence TBR measured when the lung is in the inflated state (2.0 ± 0.58) was significantly greater than in the deflated state (1.42 ± 0.38) (p<0.05). Mean fluorescence signal in tumor was highly variable across samples, (49.0 ± 18.8 AU). CT image analysis revealed greater contrast enhancement in lung tumors (a mean increase of 110 ± 57 HU) when CF800 is administered compared to the non-contrast enhanced tumors (p <0.05).

Conclusion:
This preliminary data suggests that the high fluorescence TBR demonstrated with the SPY system, and CT tumor contrast enhancement provided by CF800 may have clinical utility in aiding delineation and localization of lung cancer during CT and NIR image-guided surgery.